| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/03/2005 | US20050028226 Vaccinia virus mva-e3L-knockout-mutants and use thereof |
| 02/03/2005 | US20050027356 Microfabricated tissue as a substrate for pigment epithelium transplantation |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026854 Antibody is used to prevent, or treat of graft versus host disease; Antibody dependent cellular cytotoxicity; anti-sense nucleic acid; graft-versus-tumor activity and immunotherapy |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026292 GLYT1 conditional knock-out mice |
| 02/03/2005 | US20050026289 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/03/2005 | US20050026282 Propagating cryogenically maintained pinus embryonic stem cells; tissue engineering and plant regeneration; forest seeding |
| 02/03/2005 | US20050026281 Producing functional cotyledonary pine somatic embryos using liquid development and/or liquid stratification medium; forest regeneration and tissue engineering |
| 02/03/2005 | US20050026280 Arabidopsis thaliana mutant for use as plant model for monitoring light absorption and photosynthesis in plants |
| 02/03/2005 | US20050026279 Surgical grafts and methods of preparation |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026269 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/03/2005 | US20050026268 Phytase from Bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/03/2005 | US20050026265 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders |
| 02/03/2005 | US20050026253 Adipogenesis inhibitory factor for use as tool in identifying modulators for prevention and treatment of obesity |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050026243 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 02/03/2005 | US20050026236 PDE 10 cell-based assay and sequences |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026230 Method and apparatus for cell recovery |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026220 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/03/2005 | US20050026139 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 02/03/2005 | US20050026136 Hypoxia-mediated neurogenesis |
| 02/03/2005 | US20050026133 Cryopreservation medium for primate embryo stem cells and cryopreservation method |
| 02/03/2005 | US20050025838 Conditioned compositions for tissue restoration |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025772 Monoclonal antibody 108-394 binds to shared epitope of protein p24 and protein p26; diagnostic kits; conjugate of antibody attached to a signal generating compound; sensitivity |
| 02/03/2005 | US20050025760 Pemphigus monoclonal antibody |
| 02/03/2005 | US20050025755 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/03/2005 | US20050025754 Immunosuppression of lymphocytes by introducing a cDNA molecule encoding mutant LIGHT into the tumor, and expressing the cDNA molecule; antitumor agents, tumor antigens; drug screening |
| 02/03/2005 | US20050025752 Medical device with coating for capturing genetically-altered cells and methods for using same |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | US20050025749 Grafting heart tissue; closure of heart defect |
| 02/03/2005 | DE10362002A1 Adulte pluripotente Stammzellen Adult pluripotent stem cells |
| 02/03/2005 | DE10334825B3 Active medium for culturing neuronal cells derived from stem cells, useful e.g. for preparing in vitro nerve system models for screening, comprises basal medium of controlled inorganic ion content |
| 02/03/2005 | CA2850891A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2536644A1 Antibodies and uses thereof |
| 02/03/2005 | CA2533858A1 Compositions and methods for treating cardiac dysfunction |
| 02/03/2005 | CA2533542A1 Method of determining sperm capacitation |
| 02/03/2005 | CA2533315A1 Rat model of diabetic nephropathy |
| 02/03/2005 | CA2532939A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | CA2532754A1 Automated cell culture system and process |
| 02/03/2005 | CA2532582A1 Keratinocyte culturing method and the use thereof |
| 02/03/2005 | CA2532547A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | CA2532430A1 Humanized versions of monoclonal antibody ds6 that bind tumour antigen ca6 |
| 02/03/2005 | CA2532036A1 Methods for identifying cell surface receptor protein modulators |
| 02/03/2005 | CA2531559A1 Adenoviral e1a/e1b complementing cell line |
| 02/03/2005 | CA2530285A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2529369A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1502602A2 Methods for therapeutic vaccination |
| 02/02/2005 | EP1502110A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 02/02/2005 | EP1502108A1 Device and method for monitoring leukocyte migration |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501927A2 In vitro mutagenesis, phenotyping, and gene mapping |
| 02/02/2005 | EP1501923A2 Pak5-related compositions and methods |
| 02/02/2005 | EP1501920A2 Method for the production of cells with increased development potential |
| 02/02/2005 | EP1501919A1 Soya cell strains with high isoflavone content |
| 02/02/2005 | EP1501918A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 02/02/2005 | EP1501871A2 Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof |
| 02/02/2005 | EP1501870A2 Rsv proteins, antibodies, compositions, methods and uses |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501855A2 Novel compositions and methods in cancer |
| 02/02/2005 | EP1501854A2 Antisense modulation of hmgi-c expression |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |
| 02/02/2005 | EP1501452A2 Injectable chondrocyte implant |
| 02/02/2005 | EP1501350A2 Activation of equine oocytes |
| 02/02/2005 | EP1501345A1 Regulated ethylene sensitivity to control flower longevity in a plant |
| 02/02/2005 | EP1390379A4 Kindling fluorescent proteins and methods for their use |
| 02/02/2005 | EP1242601B1 Trichoderma reesei xylanase |
| 02/02/2005 | EP1187909B1 Fabrication of threedimensional vascularized tissue using microfabricated two-dimensional molds |
| 02/02/2005 | EP1155116B1 Use of collagenase in the preparation of neural stem cell cultures |
| 02/02/2005 | EP1141238B1 Production of proteins |
| 02/02/2005 | EP1073718A4 Nucleic acids that control seed and fruit development in plants |
| 02/02/2005 | EP1070757B1 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts |
| 02/02/2005 | EP0966534B1 Compositions and methods for elimination of unwanted cells |
| 02/02/2005 | EP0948254A4 Cell control used to confirm enzymatic activity |
| 02/02/2005 | EP0891420B1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 02/02/2005 | EP0868505B1 In vitro chondrogenic induction of human mesenchymal stem cells |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | CN1575338A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575335A Pig mast cell cultures and uses thereof |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |